Department of Cardiovascular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.
Catheter Cardiovasc Interv. 2019 Nov 1;94(5):764-772. doi: 10.1002/ccd.28131. Epub 2019 Feb 9.
Treatment of hemodynamically significant mitral annular calcification (MAC) using transcatheter approaches is in the early learning phase. The occurrence of paravalvular leak (PVL) following transcatheter mitral valve in MAC is common.
To report the initial experience and techniques of percutaneous PVL closure after transcatheter valve in MAC.
This series includes five consecutive patients who underwent percutaneous PVL closure following transcatheter balloon expandable SAPIEN S3 valve in MAC.
Mean patient age was 73.6 ± 5.4 years (4 [80%] female), with average Society of Thoracic Surgeons score of 8.1 ± 2.8%. Three patients had a single PVL defect while two patients had two defects; all were located at the commissural sites. Closure was performed primarily for heart failure in four patients and hemolytic anemia in one patient. Transfemoral transseptal antegrade approach and Amplatz Vascular Plug (AVP)-II occluders were utilized in all patients. Procedure success was achieved in three patients. One patient developed significant occluder related leaflet impingement and subsequent severe prosthetic mitral regurgitation requiring a second transcatheter mitral valve in valve implantation. The procedure was aborted in one patient due to difficulty crossing PVL defect after balloon post-dilatation of SAPIEN prosthesis with 10 mL of additional volume. There was no in hospital or 30 day mortality or the need for emergent surgery.
Early experience with percutaneous PVL closure of SAPIEN valve in MAC demonstrated feasibility of this approach. Careful procedure planning and monitoring for SAPIEN prosthesis leaflet impingement and frame instability is of utmost importance to increase the chances of procedural success.
经导管治疗血流动力学显著二尖瓣环钙化(MAC)尚处于早期学习阶段。MAC 患者行经导管二尖瓣置换术后发生瓣周漏(PVL)较为常见。
报告 MAC 患者行经导管瓣膜置换术后行经皮 PVL 封堵术的初步经验和技术。
本研究系列纳入了 5 例连续 MAC 患者行经导管球囊扩张 SAPIEN S3 瓣膜置换术后行经皮 PVL 封堵术。
患者平均年龄为 73.6±5.4 岁(4 例[80%]为女性),平均胸外科医师协会评分(STS)为 8.1±2.8%。3 例患者存在单个 PVL 缺损,2 例患者存在 2 个缺损,均位于交界部位。4 例患者因心力衰竭行封堵术,1 例患者因溶血性贫血行封堵术。所有患者均采用经股静脉经房间隔逆行入路,使用 Amplatz 血管塞(AVP)-II 封堵器。3 例患者手术成功。1 例患者发生严重瓣叶撞击和随后的重度人工二尖瓣反流,需要再次行经导管二尖瓣瓣中瓣植入术。1 例患者因 SAPIEN 假体球囊后扩张后经皮球囊未能成功跨越 PVL 缺损,且额外注入 10 mL 球囊扩张液后,出现 SAPIEN 假体框架不稳定,导致手术终止。无院内死亡或 30 天内死亡,也无需紧急手术。
MAC 患者行经导管 SAPIEN 瓣膜置换术后行经皮 PVL 封堵术的早期经验表明该方法具有可行性。仔细的手术计划和监测 SAPIEN 假体瓣叶撞击和框架不稳定对于提高手术成功率至关重要。